178 related articles for article (PubMed ID: 37822221)
21. [Antipsychotics in bipolar disorders].
Vacheron-Trystram MN; Braitman A; Cheref S; Auffray L
Encephale; 2004; 30(5):417-24. PubMed ID: 15627046
[TBL] [Abstract][Full Text] [Related]
22. Practitioner Review: The effects of atypical antipsychotics and mood stabilisers in the treatment of depressive symptoms in paediatric bipolar disorder.
Atkin T; Nuñez N; Gobbi G
J Child Psychol Psychiatry; 2017 Aug; 58(8):865-879. PubMed ID: 28474733
[TBL] [Abstract][Full Text] [Related]
23. An Oldie but Goodie: Lithium in the Treatment of Bipolar Disorder through Neuroprotective and Neurotrophic Mechanisms.
Won E; Kim YK
Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29232923
[TBL] [Abstract][Full Text] [Related]
24. Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice.
Coryell W
Bipolar Disord; 2009 Jun; 11 Suppl 2():77-83. PubMed ID: 19538687
[TBL] [Abstract][Full Text] [Related]
25. Lithium in the treatment of acute bipolar depression: A systematic review and meta-analysis.
Rakofsky JJ; Lucido MJ; Dunlop BW
J Affect Disord; 2022 Jul; 308():268-280. PubMed ID: 35429528
[TBL] [Abstract][Full Text] [Related]
26. Safety and effectiveness of continuation antidepressant versus mood stabilizer monotherapy for relapse-prevention of bipolar II depression: A randomized, double-blind, parallel-group, prospective study.
Amsterdam JD; Lorenzo-Luaces L; Soeller I; Li SQ; Mao JJ; DeRubeis RJ
J Affect Disord; 2015 Oct; 185():31-7. PubMed ID: 26143402
[TBL] [Abstract][Full Text] [Related]
27. Timing of onset of lithium relapse prevention in bipolar disorder: evidence from randomised trials.
Taylor MJ
Br J Psychiatry; 2018 Nov; 213(5):664-666. PubMed ID: 30246666
[TBL] [Abstract][Full Text] [Related]
28. Lithium and the Interplay Between Telomeres and Mitochondria in Bipolar Disorder.
Lundberg M; Millischer V; Backlund L; Martinsson L; Stenvinkel P; Sellgren CM; Lavebratt C; Schalling M
Front Psychiatry; 2020; 11():586083. PubMed ID: 33132941
[TBL] [Abstract][Full Text] [Related]
29. Valproic acid, valproate and divalproex in the maintenance treatment of bipolar disorder.
Cipriani A; Reid K; Young AH; Macritchie K; Geddes J
Cochrane Database Syst Rev; 2013 Oct; 2013(10):CD003196. PubMed ID: 24132760
[TBL] [Abstract][Full Text] [Related]
30. Clinical course and need for hospital admission after lithium discontinuation in patients with bipolar disorder type I or II: mirror-image study based on the LiSIE retrospective cohort.
Öhlund L; Ott M; Bergqvist M; Oja S; Lundqvist R; Sandlund M; Renberg ES; Werneke U
BJPsych Open; 2019 Nov; 5(6):e101. PubMed ID: 31753046
[TBL] [Abstract][Full Text] [Related]
31. Signal transduction pathways. Molecular targets for lithium's actions.
Manji HK; Potter WZ; Lenox RH
Arch Gen Psychiatry; 1995 Jul; 52(7):531-43. PubMed ID: 7598629
[TBL] [Abstract][Full Text] [Related]
32. Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study.
Biel MG; Peselow E; Mulcare L; Case BG; Fieve R
Bipolar Disord; 2007 Aug; 9(5):435-42. PubMed ID: 17680913
[TBL] [Abstract][Full Text] [Related]
33. Effects of lithium use on the white matter of patients with bipolar disorder - a systematic review.
Espanhol JCL; Vieira-Coelho MA
Nord J Psychiatry; 2022 Jan; 76(1):1-11. PubMed ID: 33969798
[TBL] [Abstract][Full Text] [Related]
34. Lithium for older adults with bipolar disorder: Should it still be considered a first-line agent?
Shulman KI
Drugs Aging; 2010 Aug; 27(8):607-15. PubMed ID: 20658789
[TBL] [Abstract][Full Text] [Related]
35. Effectiveness of mood stabilizers and antipsychotics in the maintenance phase of bipolar disorder: a systematic review of randomized controlled trials.
Smith LA; Cornelius V; Warnock A; Bell A; Young AH
Bipolar Disord; 2007 Jun; 9(4):394-412. PubMed ID: 17547586
[TBL] [Abstract][Full Text] [Related]
36. Lithium prophylaxis of depression in unipolar, bipolar II, and cyclothymic patients.
Peselow ED; Dunner DL; Fieve RR; Lautin A
Am J Psychiatry; 1982 Jun; 139(6):747-52. PubMed ID: 6805339
[TBL] [Abstract][Full Text] [Related]
37. Olanzapine: new indication. Prevention of bipolar disorder: unconvincing trials.
Prescrire Int; 2005 Aug; 14(78):140-2. PubMed ID: 16106596
[TBL] [Abstract][Full Text] [Related]
38. A clinical review of aripiprazole in bipolar depression and maintenance therapy of bipolar disorder.
Yatham LN
J Affect Disord; 2011 Jan; 128 Suppl 1():S21-8. PubMed ID: 21220077
[TBL] [Abstract][Full Text] [Related]
39. Lithium for acute mania.
McKnight RF; de La Motte de Broöns de Vauvert SJGN; Chesney E; Amit BH; Geddes J; Cipriani A
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004048. PubMed ID: 31152444
[TBL] [Abstract][Full Text] [Related]
40. Overview of lithium's use: a nationwide survey.
Pérez de Mendiola X; Hidalgo-Mazzei D; Vieta E; González-Pinto A
Int J Bipolar Disord; 2021 Mar; 9(1):10. PubMed ID: 33687600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
